| CTRI Number |
CTRI/2025/02/080398 [Registered on: 12/02/2025] Trial Registered Prospectively |
| Last Modified On: |
08/02/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Non-randomized, Active Controlled Trial |
|
Public Title of Study
|
To increase the sperm count by Gunja Moola. |
|
Scientific Title of Study
|
Evaluation of Shukra Vardhana effect of Gunja Moola in management of Ksheena Shukra or Oligospermi in adult male:A Randomised Control Clinical Trial. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Varun Kumar Dhruw |
| Designation |
PG Scholar |
| Affiliation |
Shri Narayan Prasad Awasthi Govt Ayurved college GE road raipur chhatisgarh pin code 492010 |
| Address |
Shri Narayan Prasad Awasthi Govt Ayurved college pg building first floor room number 4 GE road raipur chhatisgarh pin code 492010
Raipur CHHATTISGARH 492010 India |
| Phone |
7745980421 |
| Fax |
|
| Email |
varundhruw6355@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Pravin Kumar Joshi |
| Designation |
HOD& professor in department of Dravya Guna vigyan |
| Affiliation |
Shri Narayan Prasad Awasthi Govt Ayurved college GE road raipur chhatisgarh pin code 492010 |
| Address |
New Pg building Room number 1 first floor Shri Narayan Prasad Awasthi Govt Ayurved college pg block GE road raipur chhatisgarh pin code 492010
Raipur CHHATTISGARH 492010 India |
| Phone |
9407649488 |
| Fax |
|
| Email |
pravinkumarjoshi7000@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr C P Sinha |
| Designation |
Lecturer in Department of Kay Chikitsa |
| Affiliation |
Shri Narayan Prasad Awasthi Govt Ayurved college GE road raipur chhatisgarh pin code 492010 |
| Address |
Old UG building Room number 5 Kay chikitsa department,Shri Narayan Prasad Awasthi Govt Ayurved college GE road raipur chhatisgarh pin code 492010
Raipur CHHATTISGARH 492010 India |
| Phone |
8225000010 |
| Fax |
|
| Email |
drcspsinha@gmail.com |
|
|
Source of Monetary or Material Support
|
| Kay Chikitsa Clinic in shri khudadad dungaji Govt Ayurved college hospital GE road raipur chhatisgarh pin code 492010 |
|
|
Primary Sponsor
|
| Name |
Shri khudadad dungaji Govt Ayurved college hospital GE road raipur chhatisgarh pin code 492010 |
| Address |
Shri Narayan Prasad Awasthi Govt Ayurved college GE road raipur chhatisgarh pin code 492010 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Varun Kumar Dhruw |
Kaya Chikitsa Clinic Room number 2 in shri khudadad dungaji hospital Raipur Chhattisgarh |
Shri Narayan Prasad Awasthi Govt Ayurved college GE road raipur chhatisgarh pin code 492010 Raipur CHHATTISGARH |
7974861527
varundhruw6355@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Shri Narayan Prasad Awasthi Govt Ayurved college Raipur Chhattisgarh |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N461||Oligospermia. Ayurveda Condition: SUKRAKSHAYAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Abdus pictorius mool, Reference: Rasa Tarangani 24/459-462, Route: Oral, Dosage Form: Churna/ Powder, Dose: 4(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: Ksheera ), Additional Information: Abdus pictorius(Gunja Moola) |
|
|
|
Inclusion Criteria
|
| Age From |
25.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Male |
| Details |
Age group between 25 to 45 years.
Patients having Shastrokta symptoms of Ksheena Shukra.
Sperm count below 15 million/ml Patient with clinical presentation of Ksheena Shukra mentioned in classics i.e, Daurbalya, Panduta, Sadana, Shrama, Klaibya, Maithuna Ashakti, Chiraat Praseka, Shukra Avisarga, Medhra-Vrishana Vedana.
Patients who has given consent for clinical trial. |
|
| ExclusionCriteria |
| Details |
Age below 25 and above 45,
Sperm count not above 15 million
No sexual gland related disordes |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| There will be significant effect of Gunja Moola to improve sperm count. |
6week |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Improvement in life style |
8 weeks |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 1 |
|
Date of First Enrollment (India)
|
19/02/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="1" Days="15" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Clinical infertility is the inability of a couple to conceive after 12 months of trying. According to the WHO, roughly 1 in 6 couple has been affected. Worldwide, approximately 17.5% of the adult population is affected.The rates are comparable for high, middle and low income countries, indicating that this is a major health challenge globally.Lifetime prevalence was 17.8% in high-income countries and 16.5% in low and middle-income countries. |